Literature DB >> 16386325

In vitro evaluation of biodegradable microspheres with surface-bound ligands.

Mark E Keegan1, Sara M Royce, Tarek Fahmy, W Mark Saltzman.   

Abstract

Protein ligands were conjugated to the surface of biodegradable microspheres. These microsphere-ligand conjugates were then used in two in vitro model systems to evaluate the effect of conjugated ligands on microsphere behavior. Microsphere retention in agarose columns was increased by ligands on the microsphere surface specific for receptors on the agarose matrix. In another experiment, conjugating the lectin Ulex europaeus agglutinin 1 to the microsphere surface increased microsphere adhesion to Caco-2 monolayers compared to control microspheres. This increase in microsphere adhesion was negated by co-administration of l-fucose, indicating that the increase in adhesion is due to specific interaction of the ligand with carbohydrate receptors on the cell surface. These results demonstrate that the ligands conjugated to the microspheres maintain their receptor binding activity and are present on the microsphere surface at a density sufficient to target the microspheres to both monolayers and three-dimensional matrices bearing complementary receptors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16386325     DOI: 10.1016/j.jconrel.2005.11.004

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  17 in total

1.  Microenvironment-controlled encapsulation (MiCE) process: effects of PLGA concentration, flow rate, and collection method on microcapsule size and morphology.

Authors:  Connie Snider; Sang-Youp Lee; Yoon Yeo; Gérald J Grégori; J Paul Robinson; Kinam Park
Journal:  Pharm Res       Date:  2007-10-04       Impact factor: 4.200

2.  Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates.

Authors:  Jason Park; Thomas Mattessich; Steven M Jay; Atu Agawu; W Mark Saltzman; Tarek M Fahmy
Journal:  J Control Release       Date:  2011-06-24       Impact factor: 9.776

3.  EphA2 targeted intratumoral therapy for non-small cell lung cancer using albumin mesospheres.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Fredric Kaye; Brij M Moudgil; Najmunnisa Nasreen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

4.  Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.

Authors:  Udaya S Toti; Bharath Raja Guru; Alex E Grill; Jayanth Panyam
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

5.  Simultaneous release of multiple molecules from poly(lactide-co-glycolide) nanoparticles assembled onto medical devices.

Authors:  Catherine T Lo; Paul R Van Tassel; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-07-09       Impact factor: 12.479

6.  The uptake and intracellular fate of PLGA nanoparticles in epithelial cells.

Authors:  Malgorzata S Cartiera; Katherine M Johnson; Vanathy Rajendran; Michael J Caplan; W Mark Saltzman
Journal:  Biomaterials       Date:  2009-02-20       Impact factor: 12.479

7.  The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies.

Authors:  Khadijah M Hindi; Andrew J Ditto; Matthew J Panzner; Douglas A Medvetz; Daniel S Han; Christine E Hovis; Julia K Hilliard; Jane B Taylor; Yang H Yun; Carolyn L Cannon; Wiley J Youngs
Journal:  Biomaterials       Date:  2009-04-23       Impact factor: 12.479

8.  Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibility.

Authors:  James P Bertram; Steven M Jay; Sara R Hynes; Rebecca Robinson; Jason M Criscione; Erin B Lavik
Journal:  Acta Biomater       Date:  2009-05-04       Impact factor: 8.947

9.  Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells.

Authors:  Zhe Wang; Wai-Keung Chui; Paul C Ho
Journal:  Pharm Res       Date:  2009-02-04       Impact factor: 4.200

10.  Ligand-modified gene carriers increased uptake in target cells but reduced DNA release and transfection efficiency.

Authors:  Yen Cu; Cathy LeMoëllic; Michael J Caplan; W Mark Saltzman
Journal:  Nanomedicine       Date:  2009-10-02       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.